Miller JS - Search Results

1

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Among authors: miller w, miller js. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 Free article.

2

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1992 Nov 1;80(9):2182-7. Blood. 1992. PMID: 1384796 Free article.

3

Role of monocytes in the expansion of human activated natural killer cells.

Miller JS, Oelkers S, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1992 Nov 1;80(9):2221-9. Blood. 1992. PMID: 1421393 Free article.

4

Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1991 Jun 1;77(11):2389-95. Blood. 1991. PMID: 1903991 Free article.

5

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.

Miller JS, Alley KA, McGlave P. Miller JS, et al. Blood. 1994 May 1;83(9):2594-601. Blood. 1994. PMID: 7513206 Free article.

6

CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.

Verfaillie CM, Miller JS. Verfaillie CM, et al. Among authors: miller js. Blood. 1994 Sep 1;84(5):1442-9. Blood. 1994. PMID: 7520771 Free article.

7

Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.

Miller JS, Klingsporn S, Lund J, Perry EH, Verfaillie C, McGlave P. Miller JS, et al. Bone Marrow Transplant. 1994 Oct;14(4):555-62. Bone Marrow Transplant. 1994. PMID: 7532064

8

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al. Weisdorf DJ, et al. Among authors: miller js. Blood. 1995 Jun 15;85(12):3452-6. Blood. 1995. PMID: 7540062 Free article. Clinical Trial.

9

Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium.

Pierson BA, McGlave PB, Hu WS, Miller JS. Pierson BA, et al. Among authors: miller js. J Hematother. 1995 Jun;4(3):149-58. doi: 10.1089/scd.1.1995.4.149. J Hematother. 1995. PMID: 7551914

10

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D. Ochs L, et al. Blood. 1995 Nov 15;86(10):3979-86. Blood. 1995. PMID: 7579369 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,124 results

Search Page